Key points are not available for this paper at this time.
Answers are grounded in this paper and cite their sources.
Challenges binary AF stroke models clinically; leaves open prospective validation of continuum-based risk stratification.
Ischaemic stroke in the setting of atrial fibrillation represents one of the most challenging interfaces between cardiovascular and cerebrovascular medicine, as the prevention of thromboembolism must be continuously weighed against the competing hazard of haemorrhagic complications. Increasing evidence has progressively challenged the traditional view of atrial fibrillation as an isolated and binary determinant of stroke risk, revealing instead a complex biological continuum shaped by arrhythmic burden, atrial cardiomyopathy, occult embolic sources, systemic comorbidities, and time-dependent changes in both thrombotic and bleeding susceptibility. Within this evolving framework, the present review critically examines the pathophysiological, diagnostic, and therapeutic dimensions of the atrial fibrillation–stroke relationship, from cardioembolic mechanisms and embolic stroke of undetermined source to acute reperfusion, anticoagulation strategies, and emerging precision-medicine approaches. The overarching aim is to provide an integrated, mechanism-oriented, and clinically actionable perspective that reconciles ischaemic protection with haemorrhagic safety across the continuum of care.
No takes yet. Share an insight, caveat, or question.
Pacinella et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: